Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 17:2022:8089914.
doi: 10.1155/2022/8089914. eCollection 2022.

Efficacy Analysis of Double-Low Dynamic Contrast-Enhanced CT and Hepatic Extracellular Volume Fraction in the Diagnosis of Liver Fibrosis

Affiliations

Efficacy Analysis of Double-Low Dynamic Contrast-Enhanced CT and Hepatic Extracellular Volume Fraction in the Diagnosis of Liver Fibrosis

Zhandong Liang et al. Contrast Media Mol Imaging. .

Abstract

Objective: The aim of the study was to analyze the efficacy of double-low dynamic contrast-enhanced CT (DCE-CT) and hepatic extracellular volume fraction (fECV) in the diagnosis of liver fibrosis (LF).

Methods: A total of 200 patients with LF and cirrhosis who underwent the histopathological examination of liver biopsy and multiphase DCE-CT of the liver at the same time in our hospital (January 2020-December 2020) were selected as the research subjects, and the degree of liver fibrosis was staged according to pathological criteria to analyze the clinical diagnostic value of double-low DCE-CT and fECV.

Results: Compared with the S2-S4 group, the S1 group had obviously higher Eaorta and HCT values (P < 0.05), a lower fECV value (P < 0.001), and lower serum IVC and LN levels (P < 0.001). Serum IVC and LN levels were positively correlated with fECV (r 1 = 0.803 and r 2 = 0.890; P < 0.001). The fECV had the highest specificity and negative predictive value in the diagnosis of S1 and had the highest sensitivity and positive predictive value in the diagnosis of S2-S4.

Conclusion: The double-low DCE-CT and fECV can provide a reliable basis for the clinical diagnosis of LF, and their results will provide a new direction for the treatment of LF and have a high application value in the clinical practice.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Flow diagram of the study.
Figure 2
Figure 2
Note: (a) an image of S1; (b) an image of S2; (c) an image of S3; (d) an image of S4.
Figure 3
Figure 3
Spearman correlation analysis between fECV and serological indicators. Note: (a) correlation analysis between the IVC level and fECV and (b) correlation analysis between the LN level and fECV.
Figure 4
Figure 4
ROC curves of fECV for LF diagnosis at each stage. Note: (a) ROC curve of S1 diagnosis; (b) ROC curve of S2–4 diagnosis; (c) ROC curve of S3-4 diagnosis; (d) ROC curve of S4 diagnosis.

References

    1. Montazeri G., Rohban N., Sotoudeh M., Massarrat S. Abdominal ultrasound combined with laboratory tests as a reliable, easily accessible and cost-effective way of assessing the stages of liver fibrosis and cirrhosis. Archives of Iranian Medicine . 2022;25(2):118–123. doi: 10.34172/aim.2022.19. - DOI - PubMed
    1. Wang J., Ding W., Liu J., et al. Association of coexistent hepatitis B surface antigen and antibody with severe liver fibrosis and cirrhosis in treatment-naive patients with chronic hepatitis B. JAMA Network Open . 2022;5(6) doi: 10.1001/jamanetworkopen.2022.16485. - DOI - PMC - PubMed
    1. Yan L. T., Wang L., Yao J., et al. Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection. Medicine (Baltimore) . 2020;99(8) doi: 10.1097/md.0000000000019248. - DOI - PMC - PubMed
    1. Chen S., Jiang T. Preoperative noninvasive assessment for liver fibrosis in hepatocellular carcinoma patients with chronic hepatitis B: comparison of two-dimensional shear-wave elastography with serum liver fibrosis models. European Journal of Radiology . 2020;133 doi: 10.1016/j.ejrad.2020.109386.109386 - DOI - PubMed
    1. Ginès P., Castera L., Lammert F., et al. Population screening for liver fibrosis: toward early diagnosis and intervention for chronic liver diseases. Hepatology . 2022;75(1):219–228. doi: 10.1002/hep.32163. - DOI - PubMed

Publication types

MeSH terms